ArticlemedRxiv : the preprint server for health sciences2025
Omega-6 polyunsaturated fatty acids and adiposity in the UK Biobank Cohort: a cross-sectional and longitudinal prospective analysis.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
6 authors.
Funding
Abstract
Background: The role of omega-6 polyunsaturated fatty acids (PUFAs), especially linoleic acid (LA) in adiposity remains contested. While clinical interventions suggest improved body composition with higher LA intake, observational evidence is inconsistent, and few studies incorporate repeated measures to examine longitudinal change. Objective: To investigate associations of circulating LA, non-LA omega-6, and total omega-6 PUFAs with adiposity outcomes in the UK Biobank. Methods: Multivariable linear models evaluated cross-sectional and longitudinal associations between omega-6 fatty acid levels and waist circumference (WC), weight, and whole-body fat mass (FM) adjusting for relevant demographic, lifestyle and medical history covariates. Models considered FA levels per interquintile range and by quintiles. Results: Cross-sectionally, higher circulating LA was inversely associated with WC, weight, and FM. Participants in the highest versus lowest quintile of LA had significantly smaller WC [-11.04 (-11.17, -10.91) cm], lower weight [-11.77 (-11.92, -11.62) kg], and lower FM [-7.87 (-7.97, -7.77) kg]. Associations for total omega-6 were generally consistent with those for LA. Conversely, non-LA omega-6 was positively associated with WC [1.46 (1.32, 1.61) cm], weight [2.41 (2.25, 2.58) kg], and FM [1.81 (1.69, 1.92) kg]. Longitudinal analyses largely corroborated these patterns, with annual changes in WC, weight, and FM inversely associated with LA and positively associated with non-LA omega-6. Conclusions: Higher circulating LA, but not non-LA omega-6, was associated with lower WC, weight, and FM both cross-sectionally and longitudinally. Our findings support dietary recommendations to promote LA-rich oils. Divergent associations between LA and non-LA omega-6 caution against treating omega-6 PUFAs as a homogenous group, and there remains a need to examine the distinct health effects of individual non-LA omega-6.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.